Thomas Jefferson University

Reza Razeghinejad

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records
Address833 Chestnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Swaminathan S, Kisielewski AM, Nowroozzadeh MH, Hallaj S, Lee D, Kolomeyer NN, Myers JS, Razeghinejad R. A comparison of iCare and Goldmann applanation tonometry measurements during the COVID-19 pandemic: a retrospective study. Int Ophthalmol. 2024 Jun 23; 44(1):260. PMID: 38910200.
      Citations:    
    2. Salouti R, Azimi A, Meshksar A, Takapouy R, Ghoreyshi M, Salouti K, Razeghinejad R, Nowroozzadeh MH. Intraocular Pressure Before and After Corneal Refractive Surgery: A Prospective Comparison of Corvis ST and Ocular Response Analyzer. J Glaucoma. 2024 May 21. PMID: 38767500.
      Citations:    
    3. Baghbanmanesh A, Sadat Masoumpour M, Razeghinejad R. Full Thickness Prophylactic Scleral Windows Decrease the Rate of Choroidal Effusion and Drainage Surgery after Ahmed Glaucoma Valve Implantation. J Ophthalmic Vis Res. 2024 Jan-Mar; 19(1):6-11. PMID: 38638620.
      Citations:    
    4. Shamseldin Shalaby W, Reddy R, Razeghinejad R, Jay Katz L. Contemporary Approach to Narrow Angles. J Ophthalmic Vis Res. 2024 Jan-Mar; 19(1):88-108. PMID: 38638634.
      Citations:    
    5. Hallaj S, Sinha S, Mehran NA, Morrill AM, Pro MJ, Dale E, Schmidt C, Kolomeyer NN, Shukla AG, Lee D, Moster MR, Myers JS, Jay Katz L, Razeghinejad R. Intraocular pressure profile following selective laser trabeculoplasty in pigmentary and primary open-angle glaucoma. Eur J Ophthalmol. 2024 Mar 12; 11206721241237305. PMID: 38470322.
      Citations:    
    6. Hallaj S, Wong JC, Hock LE, Kolomeyer NN, Shukla AG, Pro MJ, Moster MR, Myers JS, Razeghinejad R, Lee D. Long-Term Surgical Outcomes of Glaucoma Drainage Implants in Eyes with Preoperative Intraocular Pressure Less than 19?mmHg. J Ophthalmol. 2024; 2024:6624021. PMID: 38304290.
      Citations:    
    7. Shalaby WS, Reddy R, Wummer B, Huang P, Lee D, Razeghinejad R, Pro MJ. Ahmed ClearPath Versus Baerveldt Glaucoma Implant: A Retrospective Non-Inferiority Comparative Study. Ophthalmol Glaucoma. 2023 Dec 27. PMID: 38158079.
      Citations:    
    8. Hallaj S, Shah SJ, Cehelyk EK, Hock LE, Lee D, Razeghinejad R, Myers JS, Frasso R, Kolomeyer NN. Empowering Family Glaucoma Risk Communication Using QR-code Mediated Online Intervention. Ophthalmol Glaucoma. 2023 Oct 12. PMID: 37838087.
      Citations:    
    9. Cherkas EG, Shields CN, Mandava N, Zhang L, Sivalingam A, Kaiser RS, Myers JS, Hammersmith KM, Razeghinejad R, Finklea BD, Shields CL, Sridhar J, Klufas MA. Virtual versus In-Person Ophthalmology Interviews: Perceptions of U.S. Ophthalmology Fellowship Applicants in 2022-2023. J Acad Ophthalmol (2017). 2023 Jul; 15(2):e197-e203. PMID: 37706000.
      Citations:    
    10. Shalaby WS, Wong JC, Zhang TZ, Hallaj S, Lam SS, Dale EA, Pro MJ, Kolomeyer NN, Shukla AG, Lee D, Myers JS, Razeghinejad R, Moster MR. Early Postoperative Aqueous Suppression Therapy and Surgical Outcomes of Ahmed Tube Shunts in Refractory Glaucoma. Ophthalmol Glaucoma. 2023 Aug 07. PMID: 37558051.
      Citations:    
    11. Shamseldin Shalaby W, Patel S, S Lam S, Ganjei A, Garg Shukla A, Kolomeyer N, Lee D, Jay Katz L, R Moster M, Myers J, Razeghinejad R. Effect of Phacoemulsification on Intraocular Pressure in Eyes with Functioning Tube Shunts. J Ophthalmic Vis Res. 2023 Apr-Jun; 18(2):150-156. PMID: 37181616.
      Citations:    
    12. Ramesh S, Shalaby WS, Myers JS, Katz LJ, Kolomeyer NN, Lee D, Razeghinejad R, Moster MR, Shukla AG. Evaluation of the Hypertensive Phase after Ahmed Glaucoma Valve Implantation in Neovascular Glaucoma. J Curr Glaucoma Pract. 2023 Apr-Jun; 17(2):91-97. PMID: 37485460.
      Citations:    
    13. Wong JC, Savsani E, Mahmoudzadeh R, Salabati M, Razeghinejad R, Lee D, Shukla AG, Myers JS, Pro MJ, Moster MR, Dunn JP, Kolomeyer NN. Glaucoma Surgical Outcomes in Patients with a History of Scleritis. Ocul Immunol Inflamm. 2023 Feb 21; 1-7. PMID: 36802353.
      Citations:    
    14. Shalaby WS, Patel S, Lam SS, Bechay J, Zadrozny I, Reyes J, Zhang Q, Sharpe J, Lee D, Myers JS, Kolomeyer NN, Razeghinejad R, Pro MJ, Moster MR, Garg Shukla A. Hemorrhagic Complications Following Trabecular Bypass Microstent Surgery in the Setting of Antithrombotic Therapy. J Glaucoma. 2023 Jan 26. PMID: 36795533.
      Citations:    
    15. Wong JC, Shiuey EJ, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Pro MJ, Lee D. The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center. Graefes Arch Clin Exp Ophthalmol. 2023 Jan; 261(1):193-200. PMID: 35904596.
      Citations:    
    16. Nowroozzadeh MH, Khatami K, Estedlal A, Emadi Z, Zarei A, Razeghinejad R. Variance in the macular sublayers' volume as a diagnostic tool for primary open-angle glaucoma. Int Ophthalmol. 2023 Jan; 43(1):261-269. PMID: 35869403.
      Citations:    
    17. Ten Hulzen RD, Wagner IV, Aref AA, Provencher LM, Razeghinejad R, Danesh-Meyer HV, Goyal S, De Francesco T, Ahmed IIK. Deadbolt cataract due to misplanted minishunt. J Cataract Refract Surg. 2022 07 01; 48(7):863. PMID: 35749070.
      Citations:    
    18. Lam SS, Amarasekera DC, Razeghinejad R. Chronic angle closure glaucoma with an atypical iris-pupillary membrane. Eur J Ophthalmol. 2022 Jun 30; 11206721221111700. PMID: 35775108.
      Citations:    
    19. Shalaby WS, Ganjei AY, Wogu B, Myers JS, Moster MR, Razeghinejad R, Lee D, Kolomeyer NN, Eid TE, Katz LJ, Shukla AG. Outcomes of Ahmed glaucoma valve and transscleral cyclophotocoagulation in neovascular glaucoma. Indian J Ophthalmol. 2022 Apr; 70(4):1253-1259. PMID: 35326027.
      Citations:    
    20. Ustaoglu M, Huynh H, Esin S, Shukla AG, Razeghinejad R. Can trainees perform Ahmed glaucoma valve surgery as effectively as attendings? Oman J Ophthalmol. 2022 Jan-Apr; 15(1):31-35. PMID: 35388262.
      Citations:    
    21. Khalili A, Razeghinejad R, Syed ZA. Anterior segment optical coherence tomography features of netarsudil-associated reticular corneal edema. Oman J Ophthalmol. 2022 Jan-Apr; 15(1):115-116. PMID: 35388265.
      Citations:    
    22. Jia JS, Shukla AG, Lee D, Razeghinejad R, Myers JS, Kolomeyer NN. What Glaucoma Patients Are Reading on the?Internet: A Systematic Analysis of Online Glaucoma Content. Ophthalmol Glaucoma. 2022 Jul-Aug; 5(4):447-451. PMID: 35114429.
      Citations:    
    23. Salouti R, Razeghinejad R, Eslami G, Zare M, Salouti K, Ghoreyshi M, Nowroozzadeh MH. Agreement of ocular response analyzer cornea compensated IOP with corvis ST biomechanical IOP following Femtosecond Laser-assisted LASIK. Eye (Lond). 2023 Feb; 37(2):263-266. PMID: 35013609.
      Citations:    
    24. Sinha S, Ganjei AY, Ustaoglu M, Syed ZA, Lee D, Myers JS, Fudemberg SJ, Razeghinejad R. Correction to: Effect of shunt type on rates of tube-cornea touch and corneal decompensation after tube shunt surgery in uveitic glaucoma. Graefes Arch Clin Exp Ophthalmol. 2021 Dec; 259(12):3823. PMID: 34097115.
      Citations:    
    25. Patel SN, Cherkas EG, Shields CN, Soares RR, Hinkle JW, Razeghinejad R, Hammersmith KM, Finklea BD, Shields CL, Cohen MN, Khan MA, Kuriyan AE, Klufas MA. Virtual Ophthalmology Fellowship Interviews: Perceptions of U.S. Ophthalmology Fellowship Applicants in 2020. J Acad Ophthalmol (2017). 2021 Jul; 13(2):e102-e107. PMID: 37388849.
      Citations:    
    26. Nowroozzadeh MH, Thornton S, Watson A, Syed ZA, Razeghinejad R. Ocular manifestations of endocrine disorders. Clin Exp Optom. 2022 03; 105(2):105-116. PMID: 34751097.
      Citations:    
    27. Shiuey EJ, Mehran NA, Ustaoglu M, Zhang Q, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Lee D. The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes. Graefes Arch Clin Exp Ophthalmol. 2022 Mar; 260(3):967-974. PMID: 34550421.
      Citations:    
    28. Shalaby WS, Lam SS, Arbabi A, Myers JS, Moster MR, Kolomeyer NN, Razeghinejad R, Shukla AG, Hussein TR, Eid TM, Shalaby SM, Lee D. iStent versus iStent inject implantation combined with phacoemulsification in open angle glaucoma. Indian J Ophthalmol. 2021 Sep; 69(9):2488-2495. PMID: 34427250.
      Citations:    
    29. Arbabi A, Bao X, Shalaby WS, Razeghinejad R. Systemic side effects of glaucoma medications. Clin Exp Optom. 2022 03; 105(2):157-165. PMID: 34402741.
      Citations:    
    30. Shalaby WS, Bechay J, Myers JS, Lee D, Razeghinejad R, Kolomeyer NN, Katz LJ, Shukla AG. Reoperation for complications within 90 days of minimally invasive glaucoma surgery. J Cataract Refract Surg. 2021 Jul 01; 47(7):886-891. PMID: 33315736.
      Citations:    
    31. Lee D, Kolomeyer NN, Razeghinejad R, Myers JS. In-vivo imaging of the conventional aqueous outflow system. Curr Opin Ophthalmol. 2021 May 01; 32(3):275-279. PMID: 33653980.
      Citations:    
    32. Shalaby WS, Arbabi A, Myers JS, Moster MR, Razeghinejad R, Katz LJ, Shukla AG. Sociodemographic and Economic Factors in Outcomes of Tube Shunts for Neovascular Glaucoma. J Curr Glaucoma Pract. 2021 May-Aug; 15(2):70-77. PMID: 34720496.
      Citations:    
    33. Shalaby WS, Razeghinejad R. Neovascularization of angle following trabeculectomy augmented with mitomycin-C. Oman J Ophthalmol. 2021 Jan-Apr; 14(1):52-55. PMID: 34084037.
      Citations:    
    34. Sinha S, Ganjei AY, Ustaoglu M, Syed ZA, Lee D, Myers JS, Fudemberg SJ, Razeghinejad R. Effect of shunt type on rates of tube-cornea touch and corneal decompensation after tube shunt surgery in uveitic glaucoma. Graefes Arch Clin Exp Ophthalmol. 2021 Jun; 259(6):1587-1595. PMID: 33515315.
      Citations:    
    35. Razeghinejad R, Gonzalez-Garcia A, Myers JS, Katz LJ. Preliminary Report on a Novel Virtual Reality Perimeter Compared With Standard Automated Perimetry. J Glaucoma. 2021 01 01; 30(1):17-23. PMID: 32941320.
      Citations:    
    36. Mehran N, Ojalvo I, Myers JS, Razeghinejad R, Lee D, Kolomeyer NN. Surgical Cancellations in Glaucoma Practice: Causes, Delays, and Effect on Patient Care and Revenue. Ophthalmol Glaucoma. 2021 Jul-Aug; 4(4):427-432. PMID: 33338680.
      Citations:    
    37. Shukla AG, Vaidya S, Yaghy A, Razeghinejad R, Mantravadi AV, Myers JS, Kaliki S, Shields CL. Transscleral Cyclophotocoagulation for Glaucoma in the Setting of Uveal Melanoma. Ophthalmol Glaucoma. 2020 Sep 19. PMID: 32956897.
      Citations:    
    38. Shalaby WS, Myers JS, Razeghinejad R, Katz LJ, Pro M, Dale E, Fudemberg SJ, Mantravadi AV, Shukla AG. Outcomes of Valved and Nonvalved Tube Shunts in Neovascular Glaucoma. Ophthalmol Glaucoma. 2021 Mar-Apr; 4(2):182-192. PMID: 32956898.
      Citations:    
    39. Razeghinejad R. Xen Luminal Obstruction. Ophthalmol Glaucoma. 2020 Sep - Oct; 3(5):376. PMID: 32980042.
      Citations:    
    40. Sinha S, Ganjei AY, McWatters Z, Lee D, Moster MR, Myers JS, Kolomeyer N, Mantravadi AV, Pro MJ, Razeghinejad R. Ahmed Versus Baerveldt Glaucoma Drainage Device in Uveitic Glaucoma: A Retrospective Comparative Study. J Glaucoma. 2020 09; 29(9):750-755. PMID: 32590449.
      Citations:    
    41. Shukla AG, Razeghinejad R, Myers JS. Balancing treatments for patients with systemic hypertension and glaucoma. Expert Opin Pharmacother. 2020 Dec; 21(18):2225-2230. PMID: 32835542.
      Citations:    
    42. Ustaoglu M, Masoumpour M, Sanvicente C, Gulati V, Razeghinejad R. Comparing the trabecular outflow by the response to topical pilocarpine in patients with and without glaucoma filtering surgery. Jpn J Ophthalmol. 2020 Nov; 64(6):591-596. PMID: 32808164.
      Citations:    
    43. Razeghinejad R, Tajbakhsh Z, Masoumpour MB, Nowroozzadeh MH. Intraocular Pressure Changes after Water Drinking Test in Surgically Treated Primary Congenital Glaucoma. J Ophthalmic Vis Res. 2020 Jul-Sep; 15(3):318-325. PMID: 32864062.
      Citations:    
    44. Zheng CX, Uhr JH, Deaner JD, Anhalt J, Lin MM, Moster SJ, Razeghinejad R. Orbital Cellulitis Following Uncomplicated Glaucoma Drainage Device Surgery: Case Report and Review of Literature. J Ophthalmic Vis Res. 2020 Jul-Sep; 15(3):412-418. PMID: 32864072.
      Citations:    
    45. Shalaby WS, Shankar V, Razeghinejad R, Katz LJ. Current and new pharmacotherapeutic approaches for glaucoma. Expert Opin Pharmacother. 2020 Nov; 21(16):2027-2040. PMID: 32717157.
      Citations:    
    46. Salouti R, Razeghinejad R, Masihpour N, Ghoreyshi M, Nowroozzadeh MH. Agreement in central corneal thickness measurement between Corvis ST and ocular response analyzer. Int Ophthalmol. 2020 Oct; 40(10):2563-2567. PMID: 32474714.
      Citations:    
    47. Machen L, Razeghinejad R, Myers JS. Fixed-combination topical anti-hypertensive ophthalmic agents. Expert Opin Pharmacother. 2020 Jul; 21(10):1269-1282. PMID: 32228188.
      Citations:    
    48. Razeghinejad R, Lin MM, Lee D, Katz LJ, Myers JS. Pathophysiology and management of glaucoma and ocular hypertension related to trauma. Surv Ophthalmol. 2020 Sep - Oct; 65(5):530-547. PMID: 32057763.
      Citations:    
    49. Mehran NA, Sinha S, Razeghinejad R. New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost. Eye (Lond). 2020 01; 34(1):72-88. PMID: 31695162.
      Citations:    
    50. Eagle RC, Razeghinejad R. Xen gel stent occlusion with iris pigment epithelium. Clin Exp Ophthalmol. 2020 03; 48(2):258-259. PMID: 31613037.
      Citations:    
    51. Sinha S, Lee D, Kolomeyer NN, Myers JS, Razeghinejad R. Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension. Expert Opin Pharmacother. 2020 Jan; 21(1):39-45. PMID: 31663782.
      Citations:    
    52. Sadat Mahmoudi Nezhad G, Razeghinejad R, Janghorbani M, Mohamadian A, Hassan Jalalpour M, Bazdar S, Salehi A, Molavi Vardanjani H. Prevalence, Incidence and Ecological Determinants of Diabetic Retinopathy in Iran: Systematic Review and Meta-analysis. J Ophthalmic Vis Res. 2019 Jul-Sep; 14(3):321-335. PMID: 31660112.
      Citations:    
    53. Razeghinejad R, Nowroozzadeh MH. Water-drinking Test and Pharmacologic Mydriasis as Provocative Tests in Primary Angle Closure Suspects. J Ophthalmic Vis Res. 2019 Jul-Sep; 14(3):267-274. PMID: 31660105.
      Citations:    
    54. Martinez P, Trubnik V, Leiby BE, Hegarty SE, Razeghinejad R, Savant S, Myers JS. A Comparative Study of the Water Drinking Test in Eyes With Open-Angle Glaucoma and Prior Trabeculectomy or Tube Shunt. J Glaucoma. 2016 Nov 21. PMID: 27875485.
      Citations:    
    Razeghinejad's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (88)
    Explore
    _
    Co-Authors (25)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _